Singapore
· Delayed Price · Currency is SGD Meta Health Statistics
Total Valuation
Meta Health has a market cap or net worth of SGD 7.22 million. The enterprise value is 7.97 million.
| Market Cap | 7.22M |
| Enterprise Value | 7.97M |
Important Dates
The last earnings date was Monday, November 4, 2024.
| Earnings Date | Nov 4, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Meta Health has 1.03 billion shares outstanding. The number of shares has increased by 23.83% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.03B |
| Shares Change (YoY) | +23.83% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 8.55% |
| Owned by Institutions (%) | 15.55% |
| Float | 924.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.27 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.20 |
| EV / Sales | 5.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.94 |
Financial Position
The company has a current ratio of 0.87
| Current Ratio | 0.87 |
| Quick Ratio | 0.86 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.99 |
| Interest Coverage | -4.41 |
Financial Efficiency
Return on equity (ROE) is -216.11% and return on invested capital (ROIC) is -11.84%.
| Return on Equity (ROE) | -216.11% |
| Return on Assets (ROA) | -6.52% |
| Return on Capital (ROIC) | -11.84% |
| Revenue Per Employee | 1,717 |
| Profits Per Employee | -7,679 |
| Employee Count | 863 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 0.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.11% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -11.11% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 32.02 |
| Average Volume (20 Days) | 514,025 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Meta Health had revenue of SGD 1.48 million and -6.63 million in losses. Loss per share was -0.01.
| Revenue | 1.48M |
| Gross Profit | 457,487 |
| Operating Income | -1.18M |
| Pretax Income | -1.90M |
| Net Income | -6.63M |
| EBITDA | -906,299 |
| EBIT | -1.18M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 1.93 million in cash and 2.69 million in debt, giving a net cash position of -759,000 or -0.00 per share.
| Cash & Cash Equivalents | 1.93M |
| Total Debt | 2.69M |
| Net Cash | -759,000 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -601,000 |
| Book Value Per Share | -0.00 |
| Working Capital | -385,000 |
Cash Flow
In the last 12 months, operating cash flow was -2.43 million and capital expenditures -279,202, giving a free cash flow of -2.71 million.
| Operating Cash Flow | -2.43M |
| Capital Expenditures | -279,202 |
| Free Cash Flow | -2.71M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 30.88% |
| Operating Margin | -79.98% |
| Pretax Margin | -128.01% |
| Profit Margin | n/a |
| EBITDA Margin | -61.18% |
| EBIT Margin | -79.98% |
| FCF Margin | -182.91% |
Dividends & Yields
Meta Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.83% |
| Shareholder Yield | -23.83% |
| Earnings Yield | -137.26% |
| FCF Yield | -37.55% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Meta Health has an Altman Z-Score of -14.37. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.37 |
| Piotroski F-Score | n/a |